Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

This will likely pump over 300$ Its pushing over vwap now and 320$ seems like a decent tp area TP1 304$ TP2 320$ TP3 344$

======= Volume ======= - neutral ========== Price Action ========== - rounding bottom recently - Ascending triangle noticed ================= Technical Indicators ================= - Ichimoku >>> price above cloud >>> Green kumo budding >>> Tenken - above clouds and pointing up >>> Chiku - within clouds and pointing up slightly >>> Kijun - Above clouds and pointing up ========= Oscillators ========= - MACD still bullish - DMI neutral - StochRSI, still bullish ========= Conclusion ========= - short to long term breakout swing - price may reverse at current level, to enter spot or wait for pullback at entry 2. ========= Positions ========= Entry - $298 Entry 2 - $286 Stop - $268 Exit 1 - $315 Exit 2 - $354 Exit 3 - $385 Exit 4 - $419 Exit 5 - $470

some divergences as well as return to narrative strong point , volume profile helps check out upside story

Looking at the daily chart of AMGN, here’s the outlook: 📊 Short-Term Outlook (1–4 weeks) Price Structure: The stock is testing a long-term ascending trendline (blue line). This level has repeatedly acted as strong support since early 2023. Risk: If buyers fail to defend the trendline, a breakdown could trigger further downside momentum. Key Support: $270 (trendline + psychological level). Short-Term Stop Loss: Below $265 on a confirmed daily close. Short-Term Target: If support holds, a rebound toward $290–300 is likely. ➡️ As long as price stays above $270, the short-term bias favors a bounce. 📊 Long-Term Outlook (2–6 months) Primary Trend: Long-term uptrend is intact, supported by the ascending trendline since 2022. Major Support Zone: $265–260 (if broken, the structure weakens significantly). Long-Term Stop Loss: Below $260 (confirmed close). Long-Term Targets: First target: $310 (previous swing highs). Next target: $330–335 if momentum continues. ➡️ Long-term bullish as long as AMGN respects the $260 support area. 🎯 Summary Short-Term Trade Idea: Buy near $270 support with a target of $290–300, stop loss at $265. Long-Term Position: Hold above $260 with upside targets at $310 and $330–335.

Testing a sell of AMGN in the strategy simulator, with first target at 270.49, second target at 260.85, and stop at 302.30

On the weekly chart, Amgen (AMGN) trades at $289.56, holding above the key $272–280 support zone, aligned with the 0.705–0.79 Fibo levels. This area forms a clear buy zone, where buyers are likely to step in. The technical structure remains bullish: the uptrend is intact, with targets at $346.85, matching historical highs and the upper boundary of the formation. Price currently sits near the lower part of the range, where volume accumulation could fuel the next upward move. Fundamentally , Amgen stands as a biotech heavyweight: its drug portfolio remains strong, late-stage pipeline candidates progress steadily, and recent earnings showed stable revenue and profit growth. Investors treat the stock as a defensive asset amid market volatility, with biotechnology demand remaining largely cycle-independent. Additionally, institutional funds have been accumulating positions, providing further support. Tactically , the $272–280 zone is critical: holding it preserves the bullish scenario. Should the bounce continue, the targets shift to $300 and $346.85. While a retest of support is possible, the broader structure remains upward. Amgen stays true to its name - when the market is sick, this stock has the cure.

My typical video consists of analyzing a specific chart and telling its story. But here, I take a different approach and analyze how to actually capitalize on the knowledge we have through the algorithms. As you'll see, these are repeated algorithms that we've identified from previous price action - and as you'll see, they repeat beautifully, over and over again, on every chart. Let's test this theory and see if we can prove an above-average/high-probability trading setup through our tapered proof and subsequent rejection. We'll check back in on AMGN to see how this plays out and to what extent of profit this setup offers us! Happy Trading :)

📈 🕒 Timeframe: 30 min 🔻 Pattern: Falling wedge nearing breakout 🔼 📍 Entry Zone: ~$277.00 ✅ 🎯 Target: $283.35 💰 🛑 Stop Loss: Below $274.00 ⚠️ 🔥 Why It Looks Bullish: 🔺 Falling wedge structure — a known bullish pattern 🧱 Strong bounce off demand zone (support + yellow line) 💚 Green reversal candle forming at wedge tip 📈 Risk-to-reward ratio is attractive for swing/short-term

📈🧬 🔺 Triangle breakout after strong recovery 📊 🎯 Target: $287.98 | 🛑 Stop: $283.80 ⚠️ Reversal from downtrend—momentum building fast! 🚀 💼 Chart analysis by #ProfittoPath 🔍 #AMGN #BiotechStocks #BreakoutTrade #TechnicalAnalysis #StockMarket